Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Enalapril overdose and the corrective effect of intravenous angiotensin II.

Literature DB >> 8527259

Enalapril overdose and the corrective effect of intravenous angiotensin II.

D E Newby, M R Lee, A J Gray, N A Boon.

Abstract

Entities: Chemical Disease Gene

Mesh：

Substances：

Year: 1995 PMID： 8527259 PMCID： PMC1365039 DOI： 10.1111/j.1365-2125.1995.tb04546.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

9 in total

1. Profound prolonged hypotension following captopril overdose.

Authors: C S Barr; R Payne; R W Newton
Journal: Postgrad Med J Date: 1991-10 Impact factor: 2.401

2. Lisinopril overdose.

Authors: A H Dawson; D Harvey; A J Smith; M Taylor; I M Whyte; C I Johnson; R B Cubela; M J Roberts
Journal: Lancet Date: 1990-02-24 Impact factor: 79.321

3. Attempted suicide with enalapril.

Authors: C P Lau
Journal: N Engl J Med Date: 1986-07-17 Impact factor: 91.245

4. Enalapril overdose treated with angiotensin infusion.

Authors: T Jackson; C Corke; J Agar
Journal: Lancet Date: 1993-03-13 Impact factor: 79.321

5. Self poisoning with enalapril.

Authors: B Waeber; J Nussberger; H R Brunner
Journal: Br Med J (Clin Res Ed) Date: 1984-01-28

6. Angiotensin inhibits action of vagus nerve at the heart.

Authors: E K Potter
Journal: Br J Pharmacol Date: 1982-01 Impact factor: 8.739

7. Acute and chronic effects of the converting enzyme inhibitors enalapril and lisinopril on reflex control of heart rate in normotensive man.

Authors: A A Ajayi; B C Campbell; C A Howie; J L Reid
Journal: J Hypertens Date: 1985-02 Impact factor: 4.844

8. Consequences of angiotensin-converting enzyme inhibitor overdose.

Authors: A Varughese; A A Taylor; E B Nelson
Journal: Am J Hypertens Date: 1989-05 Impact factor: 2.689

9. Captopril overdose resulting in hypotension.

Authors: W L Augenstein; K W Kulig; B H Rumack
Journal: JAMA Date: 1988-06-10 Impact factor: 56.272

9 in total

1. Indicators for serious kidney complications associated with toxic exposures: an analysis of the National Poison Data System.

Authors: A M Vilay; C S Wong; R M Schrader; R C Mercier; S A Seifert
Journal: Clin Toxicol (Phila) Date: 2013-01-19 Impact factor: 4.467

2. Rapid onset of haemodynamic effects after angiotensin converting enzyme-inhibitor overdose: implications for initial patient triage.

Authors: C Lucas; G A Christie; W S Waring
Journal: Emerg Med J Date: 2006-11 Impact factor: 2.740

3. Redefining the ACE-inhibitor dose-response relationship: substantial blood pressure lowering after massive doses.

Authors: G A Christie; C Lucas; D N Bateman; W S Waring
Journal: Eur J Clin Pharmacol Date: 2006-11-07 Impact factor: 2.953

Review 4. The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.

Authors: Laurence W Busse; Michael T McCurdy; Osman Ali; Anna Hall; Huaizhen Chen; Marlies Ostermann
Journal: Crit Care Date: 2017-12-28 Impact factor: 9.097

Review 5. Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety.

Authors: Laurence W Busse; Xueyuan Shelly Wang; Divya M Chalikonda; Kevin W Finkel; Ashish K Khanna; Harold M Szerlip; David Yoo; Sharon L Dana; Lakhmir S Chawla
Journal: Crit Care Med Date: 2017-08 Impact factor: 7.598

Review 6. The Role of Angiotensin II in Poisoning-Induced Shock-a Review.

Authors: Andrew Chen; Anselm Wong
Journal: J Med Toxicol Date: 2022-03-08

7. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.

Authors: Lakhmir S Chawla; Laurence Busse; Ermira Brasha-Mitchell; Danielle Davison; Jacqueline Honiq; Ziyad Alotaibi; Michael G Seneff
Journal: Crit Care Date: 2014-10-06 Impact factor: 9.097

Review 8. Angiotensin in Critical Care.

Authors: Anna Hall; Laurence W Busse; Marlies Ostermann
Journal: Crit Care Date: 2018-03-20 Impact factor: 9.097

Review 9. Angiotensin II: a new therapeutic option for vasodilatory shock.

Authors: Rachel L Bussard; Laurence W Busse
Journal: Ther Clin Risk Manag Date: 2018-07-26 Impact factor: 2.423

9 in total